Elia Bozzato - Thesis defence
ldri | Bruxelles Woluwe
Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma
Elia BOZZATO, Advanced Drug Delivery and Biomaterials (ADDB, LDRI)
Director: Prof. Véronique Préat – Co-director: Dr Chiara Bastiancich
Related publications:
- Bastiancich*, C., Bozzato*, E., et al. (2019). Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment. International journal of pharmaceutics, 559, 220-227. Published
- Bozzato, E., et al. (2021). Nanomedicine: A Useful Tool against Glioma Stem Cells. Cancers, 13(1), 9. Published
- Bastiancich*, C., Bozzato*, E., et al. (2021) "Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review." Journal of Controlled Release. Published
- Bozzato, E., et al. GSC and GBM cells elimination by a dual-drug loaded nanomedicine hydrogel. In preparation
- Gazaille, C., Bozzato E., et al. NFL peptide enhances LNC-based hydrogel effect on glioblastoma cells and prolongs animal survival. In preparation
This thesis defence took place on October 28, 2021.